• Explore /
  • Poster
  • / Impact of sarcomatoid features on treatment outcomes in metastatic clear cell renal cell carcinoma treated with first-line immunotherapy combinations.

Impact of sarcomatoid features on treatment outcomes in metastatic clear cell renal cell carcinoma treated with first-line immunotherapy combinations.

Abstract Poster

Authors

null

Kelly N. Fitzgerald

Memorial Sloan Kettering Cancer Center, New York, NY

Kelly N. Fitzgerald , Cihan Duzgol , Andrea Knezevic , Natalie Shapnik , Ritesh R Kotecha , David H Aggen , Maria Isabel Carlo , Neil J. Shah , Martin H Voss , Darren R. Feldman , Robert J. Motzer , Chung-Han Lee

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Renal Cell Cancer; Adrenal, Penile, Urethral and Testicular Cancers

Track

Renal Cell Cancer,Adrenal Cancer,Penile Cancer,Testicular Cancer,Urethral Cancer

Sub Track

Therapeutics

Citation

J Clin Oncol 41, 2023 (suppl 6; abstr 687)

DOI

10.1200/JCO.2023.41.6_suppl.687

Abstract #

687

Poster Bd #

H19

Abstract Disclosures

Similar Posters

First Author: Kelly N. Fitzgerald

First Author: Jason J. Luke

Poster

2018 ASCO Annual Meeting

Activity of targeted therapy after failure of first-line immunotherapy in BRAF-mutant metastatic melanoma.

Activity of targeted therapy after failure of first-line immunotherapy in BRAF-mutant metastatic melanoma.

First Author: Cathy Yi Xia

First Author: Ahmad A. Tarhini